跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 81 条关于
“PIV3”
全部
81
临床试验
54
药物
19
机构
0
资讯
8
11天前
Clover Reports Positive Phase 2 Data for RSV + hMPV ± PIV3 Combination Vaccines in Older Adults
11个月前
Clover Biopharmaceuticals Reports Positive Phase I Data for First-in-Class RSV-hMPV-PIV3 Combination Vaccines
11个月前
Clover Biopharmaceuticals Appoints Nicholas Jackson as President of Global R&D to Advance RSV Combination Vaccine Development
3年前
Clover Biopharmaceuticals Advances RSV Vaccine SCB-1019 with U.S. IND Clearance for Revaccination Study
去年
Sanofi Acquires Vicebio for $1.15 Billion to Expand Respiratory Vaccine Pipeline with Molecular Clamp Technology
去年
Clover Advances RSV Vaccine Program with FDA Clearance for Revaccination Trial
去年
Vicebio Secures $100 Million to Advance RSV and hMPV Combination Vaccine
10个月前
PIM3 Inhibition Restores CAR-T Cell Function in Hypoxic Solid Tumors